PALISADE BIO, INC.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $0.0 | $0.0 | $0.2 | $0.0 | — |
| Operating income | -$18.1 | -$14.9 | -$13.1 | -$15.7 | -$41.9 |
| Net income | -$16.8 | -$14.4 | -$12.3 | -$14.3 | -$26.6 |
| Balance Sheet | |||||
| Total debt | — | — | — | — | $0.1 |
| Cash Flow Statement | |||||
| Free cash flow | — | -$12.2 | -$11.1 | -$13.4 | -$14.8 |
Shares outstanding 173.6M · Free float 84.7%
Annual filing data through FY ended December 31, 2025; float as of August 25, 2026.